CRVS
Price
$5.70
Change
+$0.22 (+4.01%)
Updated
Sep 19, 10:05 AM (EDT)
42 days until earnings call
FULC
Price
$3.52
Change
+$0.08 (+2.33%)
Updated
Sep 19, 10:18 AM (EDT)
55 days until earnings call
Ad is loading...

CRVS vs FULC

Header iconCRVS vs FULC Comparison
Open Charts CRVS vs FULCBanner chart's image
Corvus Pharmaceuticals
Price$5.70
Change+$0.22 (+4.01%)
Volume$100
CapitalizationN/A
Fulcrum Therapeutics
Price$3.52
Change+$0.08 (+2.33%)
Volume$200
CapitalizationN/A
View a ticker or compare two or three
CRVS vs FULC Comparison Chart
Loading...
CRVS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
FULC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
CRVS vs. FULC commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRVS is a StrongBuy and FULC is a Hold.

COMPARISON
Comparison
Sep 19, 2024
Stock price -- (CRVS: $5.49 vs. FULC: $3.44)
Brand notoriety: CRVS and FULC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRVS: 105% vs. FULC: 78%
Market capitalization -- CRVS: $343.41M vs. FULC: $214.66M
CRVS [@Biotechnology] is valued at $343.41M. FULC’s [@Biotechnology] market capitalization is $214.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $599.73B to $0. The average market capitalization across the [@Biotechnology] industry is $3.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRVS’s FA Score shows that 0 FA rating(s) are green whileFULC’s FA Score has 1 green FA rating(s).

  • CRVS’s FA Score: 0 green, 5 red.
  • FULC’s FA Score: 1 green, 4 red.
According to our system of comparison, both CRVS and FULC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRVS’s TA Score shows that 4 TA indicator(s) are bullish while FULC’s TA Score has 4 bullish TA indicator(s).

  • CRVS’s TA Score: 4 bullish, 4 bearish.
  • FULC’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CRVS is a better buy in the short-term than FULC.

Price Growth

CRVS (@Biotechnology) experienced а +20.13% price change this week, while FULC (@Biotechnology) price change was -61.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.81%. For the same industry, the average monthly price growth was +7.77%, and the average quarterly price growth was +2.01%.

Reported Earning Dates

CRVS is expected to report earnings on Oct 31, 2024.

FULC is expected to report earnings on Nov 13, 2024.

Industries' Descriptions

@Biotechnology (+7.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRVS($343M) has a higher market cap than FULC($215M). CRVS YTD gains are higher at: 211.932 vs. FULC (-49.037). CRVS has higher annual earnings (EBITDA): -23.3M vs. FULC (-30.88M). FULC has more cash in the bank: 274M vs. CRVS (47.2M). CRVS has less debt than FULC: CRVS (700K) vs FULC (9.65M). FULC has higher revenues than CRVS: FULC (81.6M) vs CRVS (0).
CRVSFULCCRVS / FULC
Capitalization343M215M160%
EBITDA-23.3M-30.88M75%
Gain YTD211.932-49.037-432%
P/E RatioN/AN/A-
Revenue081.6M-
Total Cash47.2M274M17%
Total Debt700K9.65M7%
FUNDAMENTALS RATINGS
CRVS: Fundamental Ratings
CRVS
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
73
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRVSFULC
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
79%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 11 days ago
80%
Bullish Trend 15 days ago
89%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 7 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Ad is loading...
CRVS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
FULC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
KGDIX32.680.02
+0.06%
DWS Global Small Cap Inst
RCOCX50.59N/A
N/A
Victory RS Large Cap Alpha C
PNOBX78.08N/A
N/A
Putnam Sustainable Leaders B
EKBCX13.56N/A
N/A
Allspring Diversified Cap Bldr C
FNDMX11.90-0.07
-0.58%
Fidelity Series Sust Non-US Dev Mrkt Fd

CRVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRVS has been loosely correlated with VRDN. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CRVS jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRVS
1D Price
Change %
CRVS100%
-0.18%
VRDN - CRVS
39%
Loosely correlated
-0.57%
PRME - CRVS
35%
Loosely correlated
-0.50%
KROS - CRVS
35%
Loosely correlated
+1.22%
DYN - CRVS
35%
Loosely correlated
-0.75%
FULC - CRVS
34%
Loosely correlated
-1.43%
More

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with ONCT. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then ONCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
-1.43%
ONCT - FULC
57%
Loosely correlated
+14.19%
SLS - FULC
48%
Loosely correlated
-2.38%
ANNX - FULC
40%
Loosely correlated
-1.14%
VRDN - FULC
39%
Loosely correlated
-0.57%
STOK - FULC
35%
Loosely correlated
+0.66%
More